News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
262,793 Results
Type
Article (13649)
Company Profile (108)
Press Release (249036)
Section
Business (88001)
Career Advice (464)
Deals (15336)
Drug Delivery (64)
Drug Development (36555)
Employer Resources (49)
FDA (6269)
Job Trends (6189)
News (150116)
Policy (14015)
Tag
Academia (435)
Alliances (23169)
Alzheimer's disease (370)
Approvals (6280)
Artificial intelligence (72)
Bankruptcy (144)
Best Places to Work (4356)
Breast cancer (65)
Cancer (449)
Cardiovascular disease (47)
Career advice (406)
Cell therapy (61)
Clinical research (30620)
Collaboration (231)
Compensation (96)
COVID-19 (751)
C-suite (75)
Data (446)
Diabetes (64)
Diagnostics (1247)
Drug discovery (45)
Drug pricing (59)
Earnings (31649)
Events (37018)
Executive appointments (257)
FDA (6532)
Funding (151)
Gene therapy (72)
GLP-1 (313)
Government (1272)
Healthcare (3542)
Infectious disease (773)
Inflammatory bowel disease (50)
Interviews (58)
IPO (5846)
Job creations (2050)
Job search strategy (372)
Layoffs (170)
Legal (3416)
Lung cancer (64)
Manufacturing (112)
Medical device (1265)
Medtech (1267)
Mergers & acquisitions (9590)
Metabolic disorders (199)
Neuroscience (493)
NextGen: Class of 2025 (1581)
Non-profit (591)
Northern California (544)
Obesity (119)
Opinion (113)
Patents (70)
People (28637)
Pharmaceutical (67)
Phase I (7972)
Phase II (12944)
Phase III (11632)
Pipeline (230)
Policy (47)
Postmarket research (1401)
Preclinical (3180)
Radiopharmaceuticals (116)
Rare diseases (115)
Real estate (2631)
Regulatory (9927)
Research institute (563)
Resumes & cover letters (55)
Southern California (532)
Startups (1627)
United States (5307)
Vaccines (120)
Weight loss (86)
Date
Today (13)
Last 7 days (145)
Last 30 days (682)
Last 365 days (12375)
2025 (588)
2024 (12513)
2023 (14248)
2022 (19564)
2021 (20081)
2020 (19035)
2019 (14890)
2018 (11713)
2017 (13892)
2016 (13134)
2015 (15476)
2014 (12419)
2013 (10593)
2012 (11395)
2011 (11924)
2010 (10890)
Location
Africa (312)
Arizona (45)
Asia (19936)
Australia (2572)
California (1272)
Canada (716)
China (169)
Colorado (51)
Connecticut (54)
Europe (39011)
Florida (209)
Illinois (145)
Indiana (103)
Japan (59)
Kansas (53)
Maryland (185)
Massachusetts (1105)
Minnesota (70)
New Jersey (527)
New York (357)
North Carolina (314)
Northern California (544)
Pennsylvania (336)
South America (500)
Southern California (532)
Texas (167)
Virginia (49)
Washington State (85)
262,793 Results for "eton pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eton Pharmaceuticals Closes Acquisition of Increlex® (mecasermin injection)
December 20, 2024
·
8 min read
Press Releases
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®
January 3, 2025
·
7 min read
Press Releases
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
December 18, 2024
·
7 min read
Press Releases
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
December 3, 2024
·
5 min read
Press Releases
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
November 12, 2024
·
11 min read
Business
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, reported financial results for the quarter ended March 31, 2024.
May 9, 2024
·
10 min read
Business
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024.
April 29, 2024
·
1 min read
Press Releases
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
November 25, 2024
·
4 min read
Policy
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced the submission of a New Drug Application to the U.S. Food and Drug Administration for approval of ET-400, Eton’s proprietary patented formulation of hydrocortisone oral solution.
April 30, 2024
·
3 min read
Press Releases
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
November 7, 2024
·
3 min read
1 of 26,280
Next
